These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 15582892)

  • 1. [The surgical management of recurrent urological malignancies after primary ablative therapy].
    Galiano M; Dugardin F; Rozet F; Cathelineau X; Vallancien G
    Bull Cancer; 2004 Nov; 91(11):875-81. PubMed ID: 15582892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management of recurrent genitourinary malignancies.
    Greenberg RE; Charles RS; Samaha AM; Chelsky M; Rosen S
    Semin Oncol; 1993 Oct; 20(5):473-92. PubMed ID: 8211196
    [No Abstract]   [Full Text] [Related]  

  • 3. [Urological cancer].
    Kato M; Higashihara E
    Gan To Kagaku Ryoho; 2005 Sep; 32(9):1255-9. PubMed ID: 16184920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Essays on surgical oncourology].
    Davydov MI; Matveev VB; Volkova MI
    Vestn Ross Akad Med Nauk; 2008; (10):39-45. PubMed ID: 19140397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous laparoscopic management of 3 urological malignancies.
    Deng DY; Meng MV; Grossfeld GD; Stoller ML
    J Urol; 2002 May; 167(5):2125-6. PubMed ID: 11956456
    [No Abstract]   [Full Text] [Related]  

  • 6. [Laparoscopic surgery in urologic oncology].
    Vallancien G; Cathelineau X; Barret E; Rozet F
    Bull Acad Natl Med; 2007 Oct; 191(7):1367-73; discussion 1373-4. PubMed ID: 18447058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of provider volume on outcomes from urological cancer therapy.
    Joudi FN; Konety BR
    J Urol; 2005 Aug; 174(2):432-8. PubMed ID: 16006859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgery for the urinary tract cancer.
    Lukkarinen O
    Ann Chir Gynaecol; 1996; 85(3):202-6. PubMed ID: 8950440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of radical procedures for urologic cancer.
    Garrett JE; Rowland RG
    Surg Oncol Clin N Am; 2005 Jul; 14(3):553-68, vii. PubMed ID: 15978429
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radical laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: current status.
    Matin SF
    BJU Int; 2005 Mar; 95 Suppl 2():68-74. PubMed ID: 15720338
    [No Abstract]   [Full Text] [Related]  

  • 12. Robotic salvage retropubic prostatectomy after radiation/brachytherapy: initial results.
    Kaouk JH; Hafron J; Goel R; Haber GP; Jones JS
    BJU Int; 2008 Jul; 102(1):93-6. PubMed ID: 18410443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial comment on: Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
    Patel A
    Eur Urol; 2010 Mar; 57(3):444. PubMed ID: 19303196
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment on: Prognostic parameters, complications, and oncologic and functional outcome of salvage radical prostatectomy for locally recurrent prostate cancer after 21st-century radiotherapy.
    Ward JF
    Eur Urol; 2010 Mar; 57(3):444-5. PubMed ID: 19303198
    [No Abstract]   [Full Text] [Related]  

  • 15. [Indication and limitation of endoscopic surgery against urological cancer].
    Kondo Y; Nishimura T
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1501-5. PubMed ID: 15508440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for intravesical recurrence following urothelial carcinoma of the upper urinary tract: no relationship to the mode of surgery.
    Koda S; Mita K; Shigeta M; Usui T
    Jpn J Clin Oncol; 2007 Apr; 37(4):296-301. PubMed ID: 17513309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival.
    Bourgade V; Drouin SJ; Yates DR; Parra J; Bitker MO; Cussenot O; Rouprêt M
    World J Urol; 2014 Apr; 32(2):475-9. PubMed ID: 23455886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N; Arima K; Sugimura Y
    Int J Urol; 2008 Sep; 15(9):800-3. PubMed ID: 18651862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy.
    Nguyen CT; Lane BR; Kaouk JH; Hegarty N; Gill IS; Novick AC; Campbell SC
    J Urol; 2008 Jul; 180(1):104-9; discussion 109. PubMed ID: 18485401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of isolated renal fossa recurrence following radical nephrectomy.
    Master VA; Gottschalk AR; Kane C; Carroll PR
    J Urol; 2005 Aug; 174(2):473-7; discussion 477. PubMed ID: 16006867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.